August 31, 2021
Technological advances are speeding the development of digital measures and endpoints throughout drug development and across therapeutic areas and patient populations. While regulators encourage stakeholders to pursue patient-centric approaches, few actionable guidances or standards exist.
Digital measures of health offer enormous promise to transform how we define health and disease, and in turn improve health outcomes, economics, and equity. However, it is expensive and time-consuming to develop digital measures of health for use in healthcare and clinical research. Disjointed and undisciplined digital measure development that takes a signal chasing approach rather than measuring what matters most to patients can exacerbate the inadequacies of poor assessments in use today. It ultimately costs us the early promise of digital measures to improve the lives of patients in meaningful ways.
How can digital medicine and measurement-based care be used to promote better assessment, patient engagement and an improved quality of care? READ MORE.
Wearable technology is becoming more commonly used with individuals wanting to improve their physical and mental health. Can timely and accurate data be valuable for doctors treating patients through virtual care? READ MORE.
HOW WEARABLE DEVICES EMPOWER HEALTHCARE PROVIDERS | MedCity News
ANNOUNCEMENT: As a member of the DATAcc, Evidation is honored to collaborate with other influential stakeholders across the healthcare industry to address the challenges and importance of diversity, equity, and inclusion in digital health measurement. Guided by our mission to enable and empower everyone to participate in better health outcomes through research and health programs, we are working together to bring greater inclusivity and diversity to our Achievement platform and approaches to health measurement. READ MORE.
THOUGHT LEADERSHIP: The “behaviorome” are everyday behaviors from which data can be captured, contextualized and acted upon. At Evidation, we collaborate with influential thought leaders to contextualize data generated outside the clinic and increase the use of digital health technologies to help improve patient outcomes. READ MORE.
RESEARCH: Person-generated health data (PGHD) delivers valuable insights for cholesterol management. Evidation recruited individuals with high cholesterol to better understand how they are impacted by their condition in everyday life, including disease management. READ MORE.
RESEARCH: It takes a village to develop digital measures. Co-author and Evidationeer, Ieuan Clay, discusses the key terms related to digital measures in a unified lexicon to aid communication. READ MORE.
RESEARCH: What do study participants prefer and expect when it comes to individual research results? Patient advocate and Evidationeer, Bray Patrick-Lake, and team discuss the preferences and expectations of participants of research results within Project Baseline Health Study compared by socio demographic characteristics. READ MORE.
HEART HEALTH ON ACHIEVEMENT: Getting on the right medication is important for long-term management of heart failure and a patient’s quality of life. In our nationwide Heart Health on Achievement initiative, we see a wide variation in medication and dosage change. There are likely a range of causes – e.g, limited access to medication, knowledge etc. Further, there is no one correct medication or dosage for all patients. Patients’ wellbeing and medication response should be regularly monitored outside of the clinic, and adjusting medications and dosages is a key part of successful long-term management of heart failure. READ MORE.
GET TO KNOW YOUR EVIDATION TEAM: Meet Nikki Marinsek, Data Science Manager at Evidation, who focuses on analyzing the data that is collected in Evidation research studies in an effort to better understand people’s everyday health. READ MORE.